Isolation of CD24high and CD24low/- cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7

Cancer Letters

Volumn 258, Issue 1, 2007, Pages 98-108

  Kim, Hee Joung ^a   Kim, Jong Bin ^a   Lee, Kyung Min ^a   Shin, Incheol ^b   Han, Wonshik ^a   Ko, Eunyoung ^a   Bae, Ji Yeon ^a   Noh, Dong Young ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Adhesion; CD24; Invasion; MCF 7; Proliferation

Indexed keywords

CD24 ANTIGEN; CYCLIN D1; PROTEIN P27;

ANTIGEN EXPRESSION; ARTICLE; BIOLOGY; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL COUNT; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SELECTION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD24; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DOXORUBICIN; ESTROGEN RECEPTOR ALPHA; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; NEOPLASM INVASIVENESS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 35349025857     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.08.025     Document Type: Article

References (32)

1. List of CD molecules, prow@ncbi.nlm.nih.gov.
2. Alterman L.A., Crispe I.N., and Kinnon C. Characterization of the murine heat-stable antigen: an hematolymphoid differentiation antigen defined by the J11d, M1/69 and B2A2 antibodies. Eur. J. Immunol. 20 (1990) 1597-1602
3. Kay R., Takei F., and Humphries R.K. Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens. J. Immunol. 145 (1990) 1952-1959
4. Lavabre-Bertrand T., Duperray C., Brunet C., Poncelet P., Exbrayat C., Bourquard P., Lavabre-Bertrand C., Brochier J., Navarro M., and Janossy G. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias. Leukemia 8 (1994) 402-408
5. Agrawal S., Kuvshinoff B.W., Khoury T., Yu J., Javle M.M., LeVea C., Groth J., Coignet L.J., and Gibbs J.F. CD24 expression is an independent prognostic marker in cholangiocarcinoma. J. Gastrointest. Surg. 11 (2007) 445-451
6. Biade S., Marinucci M., Schick J., Roberts D., Workman G., Sage E.H., O'Dwyer P.J., LiVlosi V.A., and Johnson S.W. Gene expression profiling of human ovarian tumours. Br. J. Cancer 95 (2006) 1092-1100
7. Choi Y.L., Lee S.H., Kwon G.Y., Park C.K., Han J.J., Choi J.S., Choi H.Y., Kim S.H., and Shin Y.K. Overexpression of CD24; Association with invasiveness in urothelial carcinoma of the bladder. Arch. Pathol. Lab. Med. 131 (2007) 275-281
8. Karahan N., Guney M., Oral B., Kapucuoglu N., and Mungan T. CD24 expression is a poor prognostic marker in endometrial carcinoma. Eur. J. Gynaecol. Oncol. 27 (2006) 500-504
9. Lim S.C., and Oh S.H. The role of CD24 in various human epithelial neoplasias. Pathol. Res. Pract. 201 (2005) 479-486
10. Weichert W., Denkert C., Burkhardt M., Gansukh T., Bellach J., Altevogt P., Dietel M., and Kristansen G. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin. Cancer Res. 11 (2005) 6572-6581
11. Winkler A., Zigeuner W., Rehak P., Hutterer G., Chromecki T., and Langner C. CD24 expression in urothelial carcinoma of the upper urinary tract correlates tumour progression. Virchows Arch. 450 (2007) 59-64
12. Fogel M., Friederichs J., Zeller Y., Husar M., Smirnov A., Roitman L., Altevogt P., and Sthoeger Z.M. CD24 is a marker for human breast carcinoma. Cancer Lett. 143 (1999) 87-94
13. Aigner S., Ramos C.L., Hafezi-Moghadam A., Lawrence M.B., Friederichs J., Altevogt P., and Ley K. CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J. 12 (1998) 1241-1251
14. Aigner S., Sthoeger Z.M., Fogel M., Weber E., Zarn J., Rupper M., Zeller Y., Vestweber D., Stahel R., Sammar M., and Altevogt P. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89 (1997) 3385-3395
15. Baumann P., Cremers N., Kroese F., Orend G., Chiquet-Ehrismann R., Uede T., Yagita H., and Sleeman J.P. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res. 65 (2005) 10783-10793
16. Nieoullon V., Belvindrah R., Rougon G., and Chazal G. Mouse CD24 is required for homeostatic cell renewal. Cell Tissue Res. 24 (2007) Epub ahead of print
17. Bircan S., Kapucuoglu N., Baspinar S., Inan G., and Candir O. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Pathol. Res. Prac. 202 (2006) 569-576
18. Surowiak P., Materna V., Gyorffy B., Matkowski R., Wojnar A., Maciejczyk A., Paluchowski P., Dziegiel P., Pudelko M., Kornafel J., Dietel M., Kristiansen G., Zabel M., and Lage H. Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. Bri. J. Cancer 95 (2006) 339-346
19. Surowiak P., Materna V., Paluchowski P., Matkowski R., Wojnar A., Maciejczyk A., Pudelko M., Kornafel J., Dietel M., Kristiansen G., Lage H., and Zabel M. CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases. Anticanc. Res. 26 (2006) 629-634
20. Kristiansen G., Sammar M., and Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J. Mol. Histol. 35 (2004) 255-262
21. Caldon C.E., Daly R.J., Sutherland R.L., and Musgrove E.A. Cell cycle control in breast cancer cells. J. Cell Biochem. 97 (2006) 261-274
22. Colozza M., Azambuja E., Cardoso F., Sotiriou C., Larsimont D., and Piccart M.J. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?. Ann. Oncol. 16 (2005) 1723-1729
23. Ejendal K.F., and Hrycyna C.A. Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr. Protein Pept. Sci. 3 (2002) 503-511
24. Sheridan C., Kishimoto H., Fuchs R.K., Mehrotra S., Bhat-Nakshatri P., Turner C.H., Goulet Jr. R., Badve S., and Nakshatri H. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties, an early step necessary for metastasis. Br. Can. Res. 8 (2006) R59
25. Roy P.G., and Thompson A.M. Cyclin D1 and breast cancer. Breast 15 (2006) 718-727
26. Barbareschi M., van Tinteren H., Mauri F.A., Veronese S., Peterse H., Maisonneuve P., Caffo O., Scaioli M., Doglioni C., Galligioni E., Dalla Palma P., and Michalides R. p21(kip1) expression in breast carcinoma: an immunohistochemical study on 512 patients with long-term follow-up. Int. J. Cancer 89 (2000) 236-241
27. Smith S.C., Oxford G., Wu Z., Nitz M.D., Conaway M., Frierson H.F., Hampton G., and Theodorescu D. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res. 66 (2006) 1917-1922
28. Sleeman K.E., Kendrick H., Ashworth A., Isacke C.M., and Smalley M.J. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Br. Can. Res. 8 (2006) R7
29. Nieoullon V., Belvindrah R., Rougon G., and Chazal G. mCD24 regulates proliferation of neuronal committed precursors in the subventricular zone. Mol. Cell. Neurosci. 28 (2005) 462-474
30. Magnaldo T., and Barrandon Y. CD24 (heat stable antigen, nectadrin), a novel keratinocyte differentiation marker, is preferentially expressed in areas of the hair follicle containing the colony-forming cells. J. Cell Sci. 109 (1996) 3035-3045
31. Yang G.P., Ross D.T., Kuang W.W., Brown P.O., and Weigel R.J. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res. 27 (1999) 1517-1523
32. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988